Coherus Oncology Reports Third Quarter 2026 Financial Results and Announces Strategic Prioritization Plan
Coherus Oncology Announces Compelling Tagmokitug Interim Clinical Data in Esophageal Cancer and Path to Advance Development
Coherus and Zumutor Biologics Announce Clinical Collaboration to Evaluate ZM008 in Combination with LOQTORZI®
Coherus Oncology Reports Full Year and Fourth Quarter 2025 Financial Results and Provides Business Update
Michael Gentile Announces Filing of Early Warning Report Related to Acquisition of Common Shares of Cascadia Minerals Ltd.